Skip to main content
. 2020 Sep 15;9(9):2974. doi: 10.3390/jcm9092974

Table 4.

Characteristics of nutrition-related factors in elderly patients with or without sarcopenic obesity at baseline.

Sarcopenic Obesity Non-Sarcopenic Obesity
Variables (n = 31) (n = 60) p
Age (years) 73.6 ± 3.1 74.3 ± 2.9 0.36
Sex (male/female) 27/4 46/14 0.28
ASA-PS (1/2) 7/24 14/46 1.00
Body mass index (kg/m2) 22.2 ± 2.3 20.4 ± 2.8 <0.01
Body mass index >25 kg/m2 3 (9.7) 3 (5.0) 0.40
Visceral fat mass (cm²) 134.7 ± 36.8 75.0 ± 53.3 <0.01
Albumin (g/dL) 4.10 ± 0.36 4.05 ± 0.44 0.21
CCr 74.4 ± 12.5 74.1 ± 16.4 0.92
ChE 307 ± 70 281 ± 54 0.06
T-chol 188.8 ± 40.1 189.9 ± 28.5 0.88
Hb 13.8 ± 1.1 13.3 ± 1.3 0.06
SGA (A/B or C) 26/5 27/33 <0.01
Body weight loss rate (%) 1.7 ± 3.2 4.3 ± 6.2 0.03
%VC 98.6 ± 16.2 101.6 ± 14.6 0.38
%FEV1.0 77.0 ± 6.9 76.8 ± 8.3 0.90
Diabetes mellitus, n (%) 7 (22.6) 13 (21.7) 1.00
Cardiovascular disorder, n (%) 17 (54.8) 32 (53.3) 1.00
Cerebrovascular disorder, n (%) 1 (3.2) 1 (1.7) 1.00
Malignant disease, n (%) 9 (29.0) 16 (26.7) 0.81
Chronic disease, n (%) 3 (9.7) 7 (11.6) 1.00

Data are expressed as the number of cases or mean number ± standard deviation. ASA-PS, American Society of Anesthesiologists physical status; %VC, percentage vital capacity; %FEV1.0, percentage forced expiratory volume in 1 s; CCr, creatinine clearance; ChE, cholinesterase; T-chol, total cholesterol; Hb, hemoglobin; SGA, subjective global assessment.